Joel Whitley is a Partner at IAG Capital Partners since November 2019 and holds multiple board positions across various companies, including Board Member at VenoStent, Inc., NLX, Cornelis Networks, Stealth Startup Company, and Lindy Biosciences, Inc. Additionally, Joel serves as a Board Observer for Coagulo Medical Technologies, Inc., Creovai, Ordaos Bio, and Rellevate, Inc. Joel Whitley earned a J.D. in Law from the University of Chicago between 2002 and 2005 and a Bachelor of Science in Industrial and Systems Engineering from the Georgia Institute of Technology from 1997 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices